Hybridoma Technology ( Production , Purification , and Application )
Drug Resistant TB - Dr Shaz Pamangadan
1. Clinical Profile and
Treatment Outcome of
Drug Resistant
Tuberculosis
BY : Dr Shaz Pamangadan
CHAIR : Dr Balakrishnan Valliyot
2.
3.
4. MDR -TB
3.7% of new cases and
20% of previously treated cases
are estimated to have multi-drug resistant
tuberculosis worldwide.
5.
6.
7.
8.
9.
10.
11.
12.
13.
14.
15.
16.
17.
18.
19.
20.
21.
22.
23.
24.
25.
26.
27.
28.
29.
30.
31.
32.
33.
34.
35.
36.
37.
38.
39.
40.
41.
42.
43.
44.
45.
46.
47.
48.
49.
50.
51.
52.
53.
54.
55.
56.
57.
58.
59.
60.
61.
62.
63.
64.
65.
66. Objectives: This study aims to evaluate clinical profile and
treatment outcome of drug resistant tuberculosis patients at tertiary
care centre using a standardised treatment regimen (STR)
Methods: Retrospective analysis of 146 patients with DR-TB from
Solapur district who were treated with STR from period of
September 2012 to December 2014 was done. Statistical analysis of
treatment outcome data was done to know predictors of treatment
success of DR-TB.
Results: Out of total 146 bacteriologically proven cases of DR-TB,
95 were males and 51 females. 41% of patients were residents of
Solapur city and the rest from different parts of Solapur district. Out
of the 146 patients, 130 (89%) patients achieved sputum culture
conversion within three months. Treatment outcome of these
patients was as follows- treatment success in 84 (58%), 20(14%)
died, 28(19%) defaulted and failure in 14(9%) patients. Three
predictors were identified for successful treatment outcome of DR-
TB that include urban residence, patients with chest x-ray findings of
moderately advanced disease and patients whose DR-TB status
diagnosed by genexpert technology.
Conclusion: In resource-poor settings, well-designed STR under